Dave Bartosiak's technical analysis approach adds depth to our understanding Tempus AI stock chart. By paying attention to moving averages, support and resistance levels, chart patterns ...

Tempus AI (TEM) is soaring 13% today after investment bank TD Cowen reinstated coverage of the shares with a Buy rating. TEM provides next generation sequencing diagnostics, polymerase chain ...

Up about 12%, Tempus AI (NASDAQ:TEM) has been explosive. Helping, its volume just spiked to 18.6 million shares, as compared to its daily average volume of about 5.67 million. All thanks to three ...

TD Cowen analyst Dan Brennan reinstated coverage of Tempus AI (TEM) with a Buy rating and price target of $74, up from $58, following the closed of the Ambry acquisition. The deal affords Tempus ...

Whales with a lot of money to spend have taken a noticeably bearish stance on Tempus AI. Looking at options history for Tempus AI (NASDAQ:TEM) we detected 21 trades. If we consider the specifics ...

Tempus AI product lines work in concert with one another, creating a pinwheel effect as they generate data, making it more valuable over time. The company launched its 'AI-enabled personal health ...

Ryan M. Bartolucci, Chief Accounting Officer at Tempus AI , Inc. (NASDAQ:TEM), recently sold a significant portion of company stock, according to a recent SEC filing. On February 5, Bartolucci ...

We recently published a list of Top 10 AI Stocks Trending On Wall Street. In this article, we are going to take a look at where Tempus AI, Inc. (NASDAQ:TEM) stands against other top AI stocks ...

My point is this, if Tempus AI's management themselves struggle to have enough visibility into its growth rates, what hope do outside, passive investors have? Given this background, let's now ...

In a report released today, Michael Ryskin from Bank of America Securities maintained a Hold rating on Tempus AI, Inc. Class A (TEM – Research Report), with a price target of $54.00. Discover ...